Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate kainate receptors (KARs) are a subfamily of ionotropic glutamate receptors (iGluRs) that mediate fast excitatory neurotransmission in the central nervous system. They are tetrameric ligand-gated ion channels activated by glutamate and composed of GluK1-5 subunits. KARs are found both pre- and postsynaptically, modulating neurotransmitter release and synaptic plasticity. They are implicated in various neurological and psychiatric disorders including epilepsy, schizophrenia, Alzheimer’s disease, Parkinson’s disease, and autism spectrum disorder.
Ligand-gated ion channel activation; modulation of ion flow and neuronal excitability
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate Kainate Receptor (KAR).